A short clip from an optometrist on reports linking GLP-1 medications to vision loss. Little detail beyond the topic itself.
Recap by typeshit. Video by @dr.alexahecht on TikTok.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
BioPharma Dive reports the recall adds to safety worries about knockoff weight loss drugs, which stay popular despite FDA warnings and pressure from Lilly and Novo.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Loading…